Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $175
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $145 to $175.
July 30, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Tenet Healthcare and raises the price target from $145 to $175.
The raised price target and maintained Overweight rating from a reputable analyst at Wells Fargo is likely to positively impact Tenet Healthcare's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100